Pharmacokinetics in children
No information
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Cough |
- Oral
-
6 months
up to
3 years
-
0.5
- 1
mg/kg/dose,
as required 1-6 x daily. Max: 36 mg/day.
Minimum interval between 2 doses: 4 hours.
-
3 years
up to
6 years
-
7.5
mg/dose,
as required 2-4 x daily.
-
12 years
up to
18 years
-
6 years
up to
12 years
|
Renal impaiment in children > 3 months
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
HOESTPRIKKELDEMP.MIDD., EXCL COMB.PREP. MET EXPECTORANTIA
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Opium alkaloids and derivatives |
|
|
|
R05DA04
|
|
|
|
R05DA09
|
References
-
Rademaker C.M.A. et al, Geneesmiddelen-Formularium voor Kinderen, 2007
-
Teva BV, SmPC Noscapine (RVG 16680) 28-12-2020, www.cbg-meb.nl
-
Vemedia Manufacturing BV, SmPC Noscapect (RVG02256) 23-05-15, www.cbg-meb.nl
-
MMI, Online GL. Gelbe Liste Online, Accessed May 16, 2018
-
Infectopharm, SmPC CAPVAL® Dragees 25 mg Überzogene Tabletten CAPVAL® Saft 25 mg/5 g Suspension zum Einnehmen CAPVAL® Dragees 25 mg, Saft 25 mg/5 g, Tropfen 25 mg/g (6554655.00.00, 6554632.00.00, 6554589.00.00), 01/2015
-
DAZ.online, Individuell für Kinder, Accessed May 16, 2018
-
Breitkreutz J, Boos J., Paediatric and geriatric drug delivery. Expert opinion on drug delivery, 2007, 4(1), 37–45
Therapeutic Drug Monitoring
Overdose